Cambridge, MA, United States of America

Adam Charles Zelinski

This inventor holds 1 USPTO granted patent. Top assignee: Siemens Aktiengesellschaft. Active years: 2008.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adam Charles Zelinski: Innovator in Magnetic Resonance Imaging

Introduction

Adam Charles Zelinski is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of magnetic resonance imaging (MRI) through his innovative patent. His work focuses on improving the design of radio-frequency (RF) excitation pulses, which are crucial for enhancing the quality of MRI scans.

Latest Patents

Zelinski holds a patent for a "Method for designing RF excitation pulses in magnetic resonance tomography." This patent describes waveforms for RF excitation pulses that are designed using a Least Squares QR (LSQR) algorithm or a Conjugate Gradient Least Squares (CGLS) algorithm. These methods provide a solution to the linear system of equations that arises in a multi-channel RF transmit arrangement. The algorithms enable better management of specific absorption rate (SAR) and other factors, outperforming the traditionally used singular value decomposition (SVD) algorithm.

Career Highlights

Zelinski is associated with Siemens Aktiengesellschaft, a leading company in the field of medical technology. His work at Siemens has allowed him to contribute to advancements in MRI technology, enhancing the capabilities of medical imaging.

Collaborations

Zelinski has collaborated with notable colleagues such as Elfar Adalsteinsson and Kawin Setsompop. Their combined expertise has furthered the development of innovative solutions in the realm of magnetic resonance imaging.

Conclusion

Adam Charles Zelinski's contributions to the field of MRI through his patented methods demonstrate his commitment to advancing medical technology. His work continues to impact the way MRI scans are conducted, leading to improved patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…